Imidazo[1,2-a]pyridin-7-amine hydrobromide

Catalog No. :
ACLAEY381
CAS No. :
1630906-80-7
Molecular Formula :
C7H8BrN3
Molecular Weight :
214.07

IUPAC Name:imidazo[1,2-a]pyridin-7-amine hydrobromide

Imidazo[1,2-a]pyridin-7-amine hydrobromide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$75.00Login to see priceIn stockInquiry
250mg95%$100.00Login to see priceIn stockInquiry
500mg95%$168.00Login to see priceIn stockInquiry
1g95%$249.00Login to see priceIn stockInquiry
5g95%$749.00Login to see priceIn stockInquiry
10g95%$1248.00Login to see priceIn stockInquiry
25g95%$2495.00Login to see priceIn stockInquiry
50g95%$3992.00Login to see priceInquiryInquiry
100g95%$6505.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameImidazo[1,2-a]pyridin-7-amine hydrobromide
IUPAC Nameimidazo[1,2-a]pyridin-7-amine hydrobromide
MDL No.MFCD28501213
Molecular FormulaC7H8BrN3
Molecular Weight214.07
SMILESNC1=CC2=NC=CN2C=C1.[H]Br
InChI KeyUTCGATMULIAKBD-UHFFFAOYSA-N
Synonymimidazo[1,2-a]pyridin-7-amine hydrobromide;IMIDAZO[1,2-A]PYRIDIN-7-AMINE HBR;Imidazo[1,2-a]pyridin-7-amine, hydrobromide (1:1)
CAS No.1630906-80-7
PubChem CID91800846

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACLAEY381 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLAEY381 route product structure diagram
    ACLAEY3811630906-80-7 In Stock
Inquiry

2. ACLAEY381 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLAEY381 route product structure diagram
    ACLAEY3811630906-80-7 In Stock
Inquiry

Comments (0)